Sydney Jiang, MD
Otolaryngology · Richmond, INNPI 1396194148
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Stryker at 56.2% of the total. Reporting peaked in 2023 at $1,486 and has fallen 77.1% since, to $340 in 2025.
Across 62 payments — averaging $47.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Inspire Medical Systems, Inc.$722
- Intersect ENT, Inc.$265
- Smith+Nephew$179
- Aerin Medical Inc.$40
- AstraZeneca$26
- plus $50 from 3 others
What the payments were for
- Travel & lodging$1,18440%
- Food & beverage$1,61455%
- Education$1335%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 18 | $1,648 |
| Inspire Medical Systems, Inc. | 34 | $722 |
| Intersect ENT, Inc. | 2 | $265 |
| Smith+Nephew | 3 | $179 |
| Aerin Medical Inc. | 1 | $40 |
| AstraZeneca | 1 | $26 |
| Merck | 1 | $18 |
| Sanofi | 1 | $17 |
| Agiliti Surgical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SCOPIS ENT$1,117
- PROPEL$265
- Rapid Rhino - Epistaxis$133
- Coblator II$133
- Inspire$130
How this compares
$2,931 in reported general payments places this provider in the 70th percentile of 193 otolaryngology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 214 | $5,212 |
| Ipratropium Bromide | 96 | $2,784 |
| Fluticasone Propionate | 224 | $2,736 |
| Ofloxacin | 62 | $1,799 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 17 | $862 |
| Pantoprazole Sodium | 83 | $566 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 44 | $494 |
| Famotidine | 122 | $454 |
| Omeprazole | 31 | $240 |
| Mupirocin | 22 | $164 |
| Methylprednisolone | 22 | $132 |
| Gabapentin | 13 | $115 |
| Prednisone | 42 | $111 |
| Cephalexin | 15 | $71 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $45 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Richmond
- Thomas JetmoreRichmond$4K
- Rohit BawaRichmond$3K
- Joshua GreeneAnderson$955K
- Satyan SreenathIndianapolis$103K
- Stephen FreemanCarmel$33K
- Venkata KakarlapudiNew Albany$33K
- Elisa IllingIndianapolis$28K
- Colin NeumannNew Albany$26K
- Erin KevernElkhart$26K
- Aaron DubersteinLafayette$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.